Ovulation

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program
1
IbuprofenPhase 2Small Molecule1 trial
Active Trials
NCT02571543CompletedEst. Aug 2022
Pfizer
PfizerNEW YORK, NY
1 program
1
LevonorgestrelPhase 21 trial
Active Trials
NCT00254189Completed60Est. Oct 2004

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IBSA Institut BiochimiqueIbuprofen
PfizerLevonorgestrel

Clinical Trials (2)

Total enrollment: 60 patients across 2 trials

Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?

Start: Jan 2016Est. completion: Aug 2022
Phase 2Completed
NCT00254189PfizerLevonorgestrel

Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

Start: Dec 2002Est. completion: Oct 200460 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

Small Molecule is the dominant modality (100% of programs)
2 companies competing in this space